Characterization of the allosteric interactions between antagonists and amiloride analogues at the human α(2A)-adrenergic receptor

Molecular Pharmacology

Volumn 53, Issue 5, 1998, Pages 916-925

  Leppik, Ray A ^a   Lazareno, Sebastian ^b   Mynett, Anita ^a   Birdsall, Nigel J M ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b Med Res Cncl Collaborative Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 5 (N ETHYL N ISOPROPYL)AMILORIDE; 5 (N ISOBUTYL N METHYL)AMILORIDE; 5 (N,N DIMETHYL)AMILORIDE; 5 (N,N HEXAMETHYLENE)AMILORIDE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; AMILORIDE DERIVATIVE; BENZAMIL; PHENTOLAMINE; RAUWOLSCINE; YOHIMBINE;

ALLOSTERISM; ALPHA ADRENERGIC STIMULATION; ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR OCCUPANCY;

ADRENERGIC ALPHA-ANTAGONISTS; ALLOSTERIC REGULATION; AMILORIDE; ANIMALS; CHO CELLS; CRICETINAE; HUMANS; IDAZOXAN; PROTEIN BINDING; RECEPTORS, ADRENERGIC, ALPHA-2; TRITIUM; YOHIMBINE;

EID: 0031799559     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Barker JL, Harrison NL, and Mariani AP (1986) Benzodiazepine pharmacology of mammalian CNS neurons. Life Sci 39:1959-1968.
2. Birdsall NJM, Farries T, Gharagozloo P, Kobayashi S, Kuonen D, Lazareno S, Popham A, and Sugimoto M (1997) Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes. Life Sci 60:1047-1052.
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
4. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, and Trendelenburg U (1994) International Union of Pharmacology. IV. Nomenclature of adrenoceptors. Pharmacol Rev 46:121-136.
5. Caulfield MP and Birdsall NJM (1998) International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev, in press.
6. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
7. 2-adrenergic receptor in Chinese hamster ovary cells: evidence for independent pathways of receptor coupling to adenylate cyclase attenuation and activation. J Biol Chem 264:11754-11761.
8. 3H]RX821002 as radioligands. Biochim Biophys Acta 1266:207-214.
9. 2 dopamine receptors by amiloride and amiloride analogs. Mol Pharmacol 50:1295-1308.
10. 2-adrenergic receptors. Mol Pharmacol 32:53-58.
11. Hulme EC and Birdsall NJM (1992) Strategies and tactics in receptor-binding studies, in Receptor-Ligand Interactions: A Practical Approach (Hulme EC, ed) pp 63-176, IRL Press, Oxford, UK.
12. +, 5′-guanylylimidodiphosphate, amiloride and ethylisopropylamiloride: evidence for receptor-G protein precoupling. J Pharmacol Exp Ther 252:1184-1196.
13. 2;-adrenergic receptor subtypes. J Biol Chem 269:10093-10099.
14. Lazareno S and Birdsall NJM (1995) Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol Pharmacol 48:362-378.
15. Lee NH and El-Fakahany EE (1990) The allosteric binding profile of himbacine: a comparison with other cardioselective muscarinic antagonists. Eur J Pharmacol 179:225-229.
16. Lee NH and El-Fakahany EE (1991a) Allosteric antagonists of the muscarinic acetylcholine receptor. Biochem Pharmacol 42:199-205.
17. Lee NH and El-Fakahany EE (1991b) Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes. J Pharmacol Exp Ther 256:468-479.
18. 2A-adrenoceptor. Br J Pharmacol 122:69P.
19. Leppik RA, Miller RC, Eck M, and Paquet J-L (1994) Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor. Mol Pharmacol 45:983-990.
20. Matsui H, Lazareno S, and Birdsall NJM (1995) Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis. Mol Pharmacol 47:88-98.
21. + exchange. J Biol Chem 262:12387-12392.
22. Ruffolo RR Jr, Bondinell W, and Hieble JP (1995) α-and β-Adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications. J Med Chem 38:3681-3716.
23. Stockton JM, Birdsall NJM, Burgen ASV, and Hulme EC (1983) Modification of the binding properties of muscarinic receptors by gallamine. Mol Pharmacol 23:551-557.
24. Trumpp-Kallmeyer S, Hoflack J, Bruinvels A, and Hibert M (1992) Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. J Med Chem 35:3448-3462.
25. Tucek S and Proska J (1995) Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol Sci 16:205-212.
26. 2b-adrenergic receptor subtype. Mol Pharmacol 39:481-486.